Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exact Sciences Cor (NQ: EXAS ) 70.09 -0.74 (-1.04%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Exact Sciences Cor < Previous 1 2 Next > Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024 September 16, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences to Participate in September Investor Conferences August 28, 2024 From Exact Sciences Corp. Via Business Wire Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG) August 23, 2024 Via AB Newswire Exposures COVID-19 Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study August 20, 2024 From Exact Sciences Corp. Via Business Wire New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion August 15, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Announces Second-Quarter 2024 Results July 31, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences schedules second quarter 2024 earnings call July 08, 2024 From Exact Sciences Corp. Via Business Wire Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests June 18, 2024 Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including Via MarketBeat Exact Sciences to Participate in June Investor Conferences May 28, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO® May 24, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Earns 2024 Great Place To Work® Certification™ May 22, 2024 From Exact Sciences Corp. Via Business Wire Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy May 21, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Announces First-Quarter 2024 Results May 08, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024 May 07, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences to Participate in May Investor Conference May 01, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Names Aaron Bloomer as New Chief Financial Officer April 15, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes April 11, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024 April 08, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Schedules First Quarter 2024 Earnings Call April 08, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment April 04, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer March 28, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner March 27, 2024 From Exact Sciences Corp. Via Business Wire The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study March 13, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer March 07, 2024 From Exact Sciences Corp. Via Business Wire 3 Hot Stocks Bought by Members of Congress: Follow the Money March 01, 2024 Palo Alto Networks, Simon Property Group and JPMorgan Chase are the top three stocks bought by Members of Congress in February; Via MarketBeat Exact Sciences to Participate in March Investor Conference February 26, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Announces Fourth Quarter 2023 Results February 21, 2024 From Exact Sciences Corp. Via Business Wire Exact Sciences Schedules Fourth Quarter 2023 Earnings Call February 01, 2024 From Exact Sciences Corp. Via Business Wire Time to buy these 3 healthcare companies that raised revenue guidance? January 16, 2024 The new year brings a clean slate heading into the fourth-quarter earnings season. Check out a few companies that have raised revenue guidance. Via MarketBeat Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience September 12, 2023 From Agilent Technologies Inc. Via Business Wire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.